Most doctors don’t cite cost as a factor when deciding treatments
(By Ed Silverman for STAT) The rising cost of medicines may be a growing problem for many Americans, but a
Read More
Health Care – General
Biomedical Researchers Ponder Future After Trump Election
(By Richard Harris for NPR) What could the world of medical research look like under a Trump administration? Continue reading
Read MoreUpdated Medicare and Medicaid Drug Spending Dashboard
(Source -blog.cms.gov) Announcement November 14, 2016 The increased costs of prescription drugs are one of the most critical items for
Read MoreState Medicaid programs continue to restrict access to hepatitis C drugs
(By Ed Silverman for STAT) Over the past two years, state Medicaid programs have done a better job of disclosing
Read MoreDNA Is Not Destiny When It Comes To Heart Risk
(By Richard Harris for NPR) You can’t choose your parents, so you can’t help it if you’re born with genes
Read MoreVietnam Vets and Rare Form of Cancer
Ralph Erickson, who heads post-deployment health services at the Department of Veterans Affairs said about 700 Cholangiocarcinoma (caused by parasites
Read MoreAging and Affordable Housing
In a recent report by the Bipartisan Policy Center’s Senior Health and Housing Task Force, we are unprepared for the
Read MoreWhat does Donald Trump’s win mean for science and medicine?
(By Damian Garde for STAT) It’s hard to escape the din of the nation’s prognostication industry coming to terms with
Read MoreTrump, GOP In Congress Could Use “Must-Pass” Bills To Bring Health Changes
(By Julie Rovner for Kaiser Health News) Throughout the campaign, President-Elect Donald Trump’s entire health message consisted of promising to
Read MoreNovel system to get dying patients an experimental cancer drug raises hopes — and thorny questions
(By Karen Weintraub for STAT) The drug was still experimental, but clinical trials suggested it could be a lifesaver for
Read More